Tea Pemovska

2.3k total citations
25 papers, 751 citations indexed

About

Tea Pemovska is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Tea Pemovska has authored 25 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Hematology and 7 papers in Genetics. Recurrent topics in Tea Pemovska's work include Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Tea Pemovska is often cited by papers focused on Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). Tea Pemovska collaborates with scholars based in Finland, Austria and Germany. Tea Pemovska's co-authors include Krister Wennerberg, Olli Kallioniemi, Kimmo Porkka, Mika Kontro, Giulio Superti‐Furga, Johannes W. Bigenzahn, Caroline A. Heckman, Muntasir Mamun Majumder, Bhagwan Yadav and Disha Malani and has published in prestigious journals such as Nature, Nature Communications and Blood.

In The Last Decade

Tea Pemovska

24 papers receiving 739 citations

Peers

Countries citing papers authored by Tea Pemovska

Since Specialization

Citations

This map shows the geographic impact of Tea Pemovska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tea Pemovska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tea Pemovska more than expected).

Fields of papers citing papers by Tea Pemovska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tea Pemovska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tea Pemovska. The network helps show where Tea Pemovska may publish in the future.

Co-authorship network of co-authors of Tea Pemovska

This figure shows the co-authorship network connecting the top 25 collaborators of Tea Pemovska. A scholar is included among the top collaborators of Tea Pemovska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tea Pemovska. Tea Pemovska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Distinct Subtypes of Chemotherapy-Resistant Systemic ALK-Positive Anaplastic Large Cell Lymphoma Demonstrate Long-Term Complete Remissions to Imatinib 2023 ·Blood ·Alexander Pichler, Christoph Kornauth, (unknown), Lukas Kazianka, Arne Zibat, Luca Mologni, (unknown), Tea Pemovska, Gerwin Heller, Richard Greil, Lukas Kenner, Ulrich Jaeger, Philipp B. Staber	1
2	Functional Precision Medicine Vs Genomics Vs Clinical Experience: Feasibility Results from the Multicentric, Prospective, Randomized Controlled Exalt-2 Trial 2023 ·Blood ·Lukas Kazianka, Tea Pemovska, (unknown), Christoph Kornauth, Alexander Pichler, (unknown), Simone Lubowitzki, Katharina Prochazka, Peter Neumeister, Clemens A. Schmitt, Richard Greil, Wolfgang Willenbacher, Dominik Wolf‎, Ulrich Jaeger, (unknown), Philipp B. Staber	3
3	Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine 2022 ·Blood Cancer Discovery ·Tim Heinemann, Christoph Kornauth, Yannik Severin, Gregory I. Vladimer, Tea Pemovska, Emir Hadzijusufovic, Hermine Agis, Maria‐Theresa Krauth, Wolfgang R. Sperr, Peter Valent, Ulrich Jäger, Ingrid Simonitsch‐Klupp, Giulio Superti‐Furga, Philipp B. Staber, Berend Snijder	11
4	Cell-surface SLC nucleoside transporters and purine levels modulate BRD4-dependent chromatin states 2021 ·Nature Metabolism ·Kaichun Li, Enrico Girardi, Felix Kartnig, Sarah Grosche, Tea Pemovska, Johannes W. Bigenzahn, Ulrich Goldmann, Vitaly Sedlyarov, Ariel Bensimon, Sandra Schick, Jung-Ming G. Lin, Bettina Gürtl, (unknown), Kristaps Klavins, Stefan Kubicek, Sara Sdelci, Giulio Superti‐Furga	15
5	Metabolic drug survey highlights cancer cell dependencies and vulnerabilities 2021 ·Nature Communications ·Tea Pemovska, Johannes W. Bigenzahn, Ismet Srndic, Alexander Lercher, Andreas Bergthaler, Adrián César‐Razquin, Felix Kartnig, Christoph Kornauth, Peter Valent, Philipp B. Staber, Giulio Superti‐Furga	14
6	Recent advances in combinatorial drug screening and synergy scoring 2018 ·Current Opinion in Pharmacology ·Tea Pemovska, Johannes W. Bigenzahn, Giulio Superti‐Furga	84
7	Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors 2017 ·Oncotarget ·(unknown), Christopher A. Eide, (unknown), Swapnil Potdar, Heikki Kuusanmäki, Emma Andersson, John Patrick Mpindi, Tea Pemovska, Mika Kontro, Caroline A. Heckman, Olli Kallioniemi, Krister Wennerberg, Henrik Hjorth‐Hansen, Brian Druker, Jorrit M. Enserink, Jeffrey Tyner, Satu Mustjoki, Kimmo Porkka	15
8	Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia 2016 ·Leukemia ·Samuli Eldfors, Heikki Kuusanmäki, Mika Kontro, Muntasir Mamun Majumder, Alun Parsons, Henrik Edgren, Tea Pemovska, Olli Kallioniemi, Krister Wennerberg, Nicola Gökbuget, Thomas Burmeister, Kimmo Porkka, Caroline A. Heckman	41
9	HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia 2016 ·Leukemia ·Mika Kontro, Ashwini Kumar, Muntasir Mamun Majumder, Samuli Eldfors, Alun Parsons, Tea Pemovska, Jani Saarela, Bhagwan Yadav, Disha Malani, Yngvar Fløisand, Martin Höglund, Kari Remes, Bjørn Tore Gjertsen, Olli Kallioniemi, Krister Wennerberg, Caroline A. Heckman, Kimmo Porkka	66
10	Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML 2016 ·Leukemia ·Disha Malani, Astrid Murumägi, Bhagwan Yadav, Mika Kontro, Samuli Eldfors, Ashwini Kumar, Riikka Karjalainen, Muntasir Mamun Majumder, (unknown), Tea Pemovska, Krister Wennerberg, Caroline A. Heckman, Kimmo Porkka, Maija Wolf, Tero Aittokallio, Olli Kallioniemi	44
11	Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia 2016 ·European Journal of Cancer ·Samuli Eldfors, Heikki Kuusanmäki, Mika Kontro, Muntasir Mamun Majumder, Alun Parsons, Henrik Edgren, Tea Pemovska, Olli Kallioniemi, Krister Wennerberg, Nicola Gökbuget, Thomas Burmeister, Kimmo Porkka, Caroline A. Heckman	7
12	Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing 2015 ·Blood Cancer Journal ·(unknown), Tea Pemovska, Mika Kontro, Bhagwan Yadav, John-Patrick Mpindi, Emma Andersson, Muntasir Mamun Majumder, Heikki Kuusanmäki, Perttu Koskenvesa, Olli Kallioniemi, Krister Wennerberg, Caroline A. Heckman, Satu Mustjoki, Kimmo Porkka	18
13	Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation 2015 ·Nature ·Tea Pemovska, Eric F. Johnson, Mika Kontro, Gretchen A. Repasky, Jeffrey Chen, Peter A. Wells, Ciarán N. Cronin, Michele McTigue, Olli Kallioniemi, Kimmo Porkka, Brion W. Murray, Krister Wennerberg	172
14	Individualised systems medicine: Next-generation precision cancer medicine and drug positioning 2015 ·Tea Pemovska, Päivi Östling, Caroline A. Heckman, Olli Kallioniemi, Krister Wennerberg	1
15	Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies 2014 ·Scientific Reports ·Bhagwan Yadav, Tea Pemovska, Agnieszka Szwajda, Evgeny Kulesskiy, Mika Kontro, Riikka Karjalainen, Muntasir Mamun Majumder, Disha Malani, Astrid Murumägi, Jonathan C. Knowles, Kimmo Porkka, Caroline A. Heckman, Olli Kallioniemi, Krister Wennerberg, Tero Aittokallio	214
16	A personalised medicine drug sensitivity and resistance testing platform and utilisation of acoustic droplet ejection at the Institute for Molecular Medicine Finland 2014 ·Jani Saarela, Evgeny Kulesskiy, (unknown), Tea Pemovska, Vilja Pietiäinen, Swapnil Potdar, (unknown), Laura Turunen, Päivi Östling, Krister Wennerberg	3
17	Discovery of Novel Drug Sensitivities in T-Prolymphocytic Leukemia (T-PLL) By High-Throughput Ex Vivo Drug Testing and Genetic Profiling 2014 ·Blood ·Emma Andersson, Leopold Sellner, Małgorzata Oleś, Tea Pemovska, (unknown), Anneli Lauhio, (unknown), Carlos Cuesta‐Mateos, Edgar Faber, Tim H. Brümmendorf, Olli Kallioniemi, Kimmo Porkka, Caroline A. Heckman, Wolfgang Huber, Krister Wennerberg, Thorsten Zenz, Satu Mustjoki	1
18	826: Primary T-prolymphocytic leukemia (T-PLL) cells are sensitive to BCL-2 and HDAC inhibitors: Results from high-throughput ex vivo drug testing 2014 ·European Journal of Cancer ·Emma Andersson, Tea Pemovska, Anneli Lauhio, (unknown), (unknown), Edgar Faber, Tim H. Brümmendorf, Olli Kallioniemi, Krister Wennerberg, Satu Mustjoki	1
19	Novel Activating STAT5B Mutations As Drivers Of T-ALL 2013 ·Blood ·Mika Kontro, Heikki Kuusanmäki, Samuli Eldfors, Tea Pemovska, Hanna Rajala, Henrik Edgren, Pekka Ellonen, Sonja Lagström, Tuija Lundán, Olli Kallioniemi, Satu Mustjoki, Kimmo Porkka, Caroline A. Heckman	2
20	Development of metastatic HER2⁺ breast cancer is independent of the adaptive immune system 2010 ·The Journal of Pathology ·Metamia Ciampricotti, Kim Vrijland, Cheei‐Sing Hau, Tea Pemovska, Chris W. Doornebal, Ewoud N. Speksnijder, Katharina Wartha, Jos Jonkers, Karin E. de Visser	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact